TMPO and non-small cell lung carcinoma: Yu et al., in 2020, found that TMPO-AS1 was upregulated in the cancerous tissues of NSCLC samples, which enhanced the expression of ERBB2, promoting the deterioration of NSCLC cells (Yu et al., 2020).